<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Perez, H.A.</style></author><author><style face="normal" font="default" size="100%">Allende, G.F.</style></author><author><style face="normal" font="default" size="100%">E. I. O. Ajayi</style></author><author><style face="normal" font="default" size="100%">Portal, D. J.</style></author><author><style face="normal" font="default" size="100%">Garcia, N. H.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Atherosclerosis plaque area reduction: working hypothesis to prevent cardiovascular event</style></title><secondary-title><style face="normal" font="default" size="100%">Comparative Clinical Pathology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://doi.org/10.1007/s00580-018-2868-1</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">28</style></volume><pages><style face="normal" font="default" size="100%">907-914</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Cardiovascular events are the leading cause of death worldwide. In this sense,&amp;nbsp;cardiovascular diseases (CVD) are the main products of atherosclerosis (ATR),&amp;nbsp;whose origin is multifactorial. The measurable identification of the so-called&amp;nbsp;cardiovascular risk factors (CRF) was a great advance for its prevention.&amp;nbsp;Scientific evidences have shown that the reduction of mortality due to&amp;nbsp;cardiovascular disease is an important achievement of the optimal control of&amp;nbsp;CRF. However, a large proportion of patients have cardiovascular events when&amp;nbsp;CRF is controlled. It is therefore imperative to stratify the patient’s risk in&amp;nbsp;order to design the specific and individual treatment strategy. Currently, there&amp;nbsp;are cardiovascular risk classification (CVR) scales that contemplate the&amp;nbsp;combination of the multiple CRF that patients may present, although it is&amp;nbsp;known that most of these algorithms sub- or overestimate the possibility of&amp;nbsp;cardiovascular events. The incorporation of intermediate cardiovascular&amp;nbsp;surrogates to CRF and events, such as the measurement of carotid&amp;nbsp;atherosclerosis, is demonstrating an improvement in the diagnosis and fewer&amp;nbsp;events in the healthy population, with high cardiovascular risk, treated with&amp;nbsp;the incorporation of these to the diagnostic and therapeutic algorithms.&lt;/p&gt;
&lt;p&gt;Keywords Prevention of cardiovascular event, Carotid atherosclerosis, Vascular Doppler, Hypertension, Prevention diet therapy&lt;/p&gt;</style></abstract></record></records></xml>